Literature DB >> 25870317

British Thoracic Society guidelines for home oxygen use in adults.

Maxine Hardinge1, Joe Annandale2, Simon Bourne3, Brendan Cooper4, Angela Evans5, Daryl Freeman6, Angela Green7, Sabrine Hippolyte8, Vikki Knowles9, William MacNee10, Lynn McDonnell11, Kathy Pye12, Jay Suntharalingam13, Vandana Vora14, Tom Wilkinson15.   

Abstract

The British Thoracic Society (BTS) Home Oxygen Guideline provides detailed evidence-based guidance for the use of home oxygen for patients out of hospital. Although the majority of evidence comes from the use of oxygen in patients with chronic obstructive pulmonary disease, the scope of the guidance includes patients with a variety of long-term respiratory illnesses and other groups in whom oxygen is currently ordered, such as those with cardiac failure, cancer and end-stage cardiorespiratory disease, terminal illness or cluster headache. It explores the evidence base for the use of different modalities of oxygen therapy and patient-related outcomes such as mortality, symptoms and quality of life. The guideline also makes recommendations for assessment and follow-up protocols, and risk assessments, particularly in the clinically challenging area of home oxygen users who smoke. The guideline development group is aware of the potential for confusion sometimes caused by the current nomenclature for different types of home oxygen, and rather than renaming them, has adopted the approach of clarifying those definitions, and in particular emphasising what is meant by long-term oxygen therapy and palliative oxygen therapy. The home oxygen guideline provides expert consensus opinion in areas where clinical evidence is lacking, and seeks to deliver improved prescribing practice, leading to improved compliance and improved patient outcomes, with consequent increased value to the health service. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Long Term Oxygen Therapy (LTOT)

Mesh:

Substances:

Year:  2015        PMID: 25870317     DOI: 10.1136/thoraxjnl-2015-206865

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  65 in total

1.  In Reply.

Authors:  Andreas Rembert Koczulla
Journal:  Dtsch Arztebl Int       Date:  2019-04-19       Impact factor: 5.594

2.  Long-Term Oxygen Therapy.

Authors:  Andreas Rembert Koczulla; Tessa Schneeberger; Inga Jarosch; Klaus Kenn; Rainer Gloeckl
Journal:  Dtsch Arztebl Int       Date:  2018-12-24       Impact factor: 5.594

3.  Wrist-Sensor Pulse Oximeter Enables Prolonged Patient Monitoring in Chronic Lung Diseases.

Authors:  Alexander Guber; Gali Epstein Shochet; Sarah Kohn; David Shitrit
Journal:  J Med Syst       Date:  2019-06-14       Impact factor: 4.460

Review 4.  Updates in palliative care - recent advancements in the pharmacological management of symptoms.

Authors:  Angela Star; Jason W Boland
Journal:  Clin Med (Lond)       Date:  2018-02       Impact factor: 2.659

Review 5.  Quality of smoking cessation advice in guidelines of tobacco-related diseases: An updated systematic review.

Authors:  Winifred Ekezie; Rachael L Murray; Sanjay Agrawal; Ilze Bogdanovica; John Britton; Jo Leonardi-Bee
Journal:  Clin Med (Lond)       Date:  2020-11       Impact factor: 2.659

6.  Assessment of knowledge, attitude and practice regarding oxygen therapy at emergency departments in Riyadh in 2017: A cross-sectional study.

Authors:  Amairah Fahad Aloushan; Faisal Abdullah Almoaiqel; Raid Naysh Alghamdi; Fatmah Ismail Alnahari; Abdulaziz Fahad Aldosari; Nazish Masud; Nawfal Abdullah Aljerian
Journal:  World J Emerg Med       Date:  2019

Review 7.  Ambulatory and short-burst oxygen for interstitial lung disease.

Authors:  Charles Sharp; Huzaifa Adamali; Ann B Millar
Journal:  Cochrane Database Syst Rev       Date:  2016-07-06

8.  Pharmacological Management of People Living with End-Stage Chronic Obstructive Pulmonary Disease.

Authors:  Victoria Dalgliesh; Hilary Pinnock
Journal:  Drugs Aging       Date:  2017-04       Impact factor: 3.923

9.  Cost-Effectiveness of Domiciliary High Flow Nasal Cannula Treatment in COPD Patients with Chronic Respiratory Failure.

Authors:  Sabrina Storgaard Sørensen; Line Hust Storgaard; Ulla Møller Weinreich
Journal:  Clinicoecon Outcomes Res       Date:  2021-06-18

10.  Resilience and health-related quality of life in patients with pulmonary diseases receiving ambulatory oxygen therapy.

Authors:  Siiri Isokääntä; Kirsi Honkalampi; Hannu Kokki; Harri Sintonen; Merja Kokki
Journal:  BMC Pulm Med       Date:  2021-05-01       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.